InvestorsHub Logo
icon url

chickpea598

03/29/18 10:56 AM

#43506 RE: Waitforit53 #43505

As stated in the past Oncosec sees an exit opportunity with PISCES data release. If the news is good I do believe they get a buyout offer from Merck. At this point does Oncosec accept an offer. With the possibility to expand the pipeline and grow organically...TNBC news from AACR will shed more light on things. Maybe they decide to stick with licensing or maybe a buyout offer will be much higher than expected and too good to pass up.
icon url

zb19812013

03/29/18 7:32 PM

#43527 RE: Waitforit53 #43505

15 bucks a share would be a disappointment. Anything than less than a one billion dollar buy out would be a disappointment, IMO. I could have sold it pre-split for the equivalent of about $15 bucks a share